Literature DB >> 6584663

Selective degradation of basement membrane macromolecules by metastatic melanoma cells.

R H Kramer, K G Vogel.   

Abstract

The extracellular matrix deposited in culture by the mouse endodermal cell line (PF HR9) was used as an experimental model to study the interactions between basement membranes and several tumorigenic and nontumorigenic cell lines, including the metastatic B16 melanoma cell sublines. Analysis by biochemical and immunologic methods indicated that the isolated HR9 extracellular matrix was composed of laminin, type IV collagen, entactin, and heparan sulfate proteoglycans--all basement membrane-specific macromolecules. Ultrastructurally, the extracellular matrix elaborated by the HR9 cells appears as a meshwork of finely fibrillar material. B16 melanoma cells were found to adhere rapidly to the isolated HR9 matrix, but significant penetration into the structure was not observed. However, the melanoma cells did induce an extensive solubilization of 35S-sulfate-labeled heparan sulfate to fragments that were approximately one-third the size of the intact heparan sulfate chains. Only the B16 melanoma sublines exhibited this unique pattern of proteoglycan degradation, which suggests that they possess an endoglycosidase specific for heparan sulfate chains. B16 melanoma cells seeded onto HR9 matrices labeled with [1H]leucine or [3H]proline caused no detectable increase in matrix protein solubilization compared to controls. The results indicate that the metastatic tumor cells degrade the proteoglycans in the HR9 matrix more readily than the other matrix proteins.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6584663

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  17 in total

Review 1.  Cell-matrix interactions during tumor invasion.

Authors:  J R Starkey
Journal:  Cancer Metastasis Rev       Date:  1990-09       Impact factor: 9.264

Review 2.  Do circulating tumor cells, exosomes, and circulating tumor nucleic acids have clinical utility? A report of the association for molecular pathology.

Authors:  Bert Gold; Milena Cankovic; Larissa V Furtado; Frederick Meier; Christopher D Gocke
Journal:  J Mol Diagn       Date:  2015-05       Impact factor: 5.568

3.  A rapid and sensitive fluorometric screening assay using YO-PRO-1 to quantify tumour cell invasion through Matrigel.

Authors:  A Gohla; K Eckert; H R Maurer
Journal:  Clin Exp Metastasis       Date:  1996-10       Impact factor: 5.150

4.  In vitro inhibition of human sarcoma cells' invasive ability by bis(5-amidino-2-benzimidazolyl)methane--a novel esteroprotease inhibitor.

Authors:  D H Cresson; W C Beckman; R R Tidwell; J D Geratz; G P Siegal
Journal:  Am J Pathol       Date:  1986-04       Impact factor: 4.307

Review 5.  The role of cell adhesion proteins--laminin and fibronectin--in the movement of malignant and metastatic cells.

Authors:  J B McCarthy; M L Basara; S L Palm; D F Sas; L T Furcht
Journal:  Cancer Metastasis Rev       Date:  1985       Impact factor: 9.264

6.  Accumulation of heparan sulfate in the culture of human melanoma cells with different metastatic ability.

Authors:  M Moczar; F Caux; M Bailly; O Berthier; J F Doré
Journal:  Clin Exp Metastasis       Date:  1993-11       Impact factor: 5.150

7.  Molecular and cellular analysis of basement membrane invasion by human breast cancer cells in Matrigel-based in vitro assays.

Authors:  S N Bae; G Arand; H Azzam; P Pavasant; J Torri; T L Frandsen; E W Thompson
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

8.  Attachment of oral bacteria to a basement-membrane-like matrix and to purified matrix proteins.

Authors:  J R Winkler; S R John; R H Kramer; C I Hoover; P A Murray
Journal:  Infect Immun       Date:  1987-11       Impact factor: 3.441

Review 9.  Proteoglycans and neoplasia.

Authors:  R V Iozzo
Journal:  Cancer Metastasis Rev       Date:  1988-04       Impact factor: 9.264

Review 10.  Organ specificity of tumor metastasis: role of preferential adhesion, invasion and growth of malignant cells at specific secondary sites.

Authors:  G L Nicolson
Journal:  Cancer Metastasis Rev       Date:  1988-06       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.